-
Something wrong with this record ?
Added Value in Low-Risk Pregnancies of Longitudinal Changes in Uterine Doppler and Circulating Angiogenic Factors during the Third Trimester in Predicting Term Preeclampsia
L. Roubalova, V. Kroutilova, MF. Lopez-G Tinajero, J. Martinez-Egea, C. Pumarola, F. Figueras, M. Lubusky
Language English
Document type Comparative Study, Journal Article, Multicenter Study, Randomized Controlled Trial
PubMed
39496230
DOI
10.1159/000541731
Knihovny.cz E-resources
- MeSH
- Adult MeSH
- Humans MeSH
- Placental Circulation physiology MeSH
- Placenta Growth Factor * blood MeSH
- Area Under Curve MeSH
- Predictive Value of Tests MeSH
- Pre-Eclampsia * blood diagnostic imaging MeSH
- Vascular Endothelial Growth Factor Receptor-1 * blood MeSH
- Rheology * methods statistics & numerical data MeSH
- Reproducibility of Results MeSH
- Blood Flow Velocity physiology MeSH
- Pregnancy MeSH
- Pregnancy Trimester, Third * blood physiology MeSH
- Ultrasonography, Doppler methods statistics & numerical data MeSH
- Ultrasonography, Prenatal * methods statistics & numerical data MeSH
- Check Tag
- Adult MeSH
- Humans MeSH
- Pregnancy MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Multicenter Study MeSH
- Randomized Controlled Trial MeSH
- Comparative Study MeSH
INTRODUCTION: The objective of this study was to assess the relationship between longitudinal changes in the uterine Doppler velocimetry and the maternal profile of angiogenic factors in the third trimester and to assess their ability to predict term preeclampsia (PE). METHODS: A cohort of low-risk pregnant women was scheduled for a uterine Doppler evaluation and measurement of the circulating levels of angiogenic factors at ∼30 and ∼36 weeks. The performance of both parameters and their change over time in predicting term PE was evaluated. RESULTS: A total of 1,191 women were analyzed, of which 28 (2.4%) women developed term PE. At ∼30 weeks, a model including the sFlt-1/PlGF (fms-like tyrosine kinase-1/placental growth factor) ratio and the uterine Doppler explained 16.2% of the uncertainty of developing term PE, while at ∼36 weeks, the same variables explained 25.2% [p < 0.001]. The longitudinal changes of both predictors had an R2 of 26.8%, which was not different from that of the ∼36 weeks evaluation [p = 0.45]. The area under the curve (AUC) of the ∼36 weeks ratio was significantly higher than at ∼30 weeks (0.86 [0.77-0.94] vs. 0.81 [0.73-0.9]; p = 0.043). The AUC of the longitudinal change of the ratio (0.85 [0.77-0.94]) did not differ from that of at ∼36 weeks (p = 0.82). At ∼36 weeks, for a 10% of false positives, the ratio had a detection rate of 71.4%. CONCLUSION: A cross-sectional measurement of the sFlt-1/PlGF ratio outperforms uterine Doppler in predicting term PE. The combination of both markers does not improve such prediction, nor the evaluation of the longitudinal changes between weeks.
BCNatal Universitat de Barcelona Barcelona Spain
Department of Obstetrics and Gynecology Palacky University Olomouc Olomouc Czechia
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc25016435
- 003
- CZ-PrNML
- 005
- 20250731092912.0
- 007
- ta
- 008
- 250708s2025 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1159/000541731 $2 doi
- 035 __
- $a (PubMed)39496230
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a x
- 100 1_
- $a Roubalova, Lucie $u Department of Obstetrics and Gynecology, Palacky University Olomouc, Olomouc, Czechia
- 245 10
- $a Added Value in Low-Risk Pregnancies of Longitudinal Changes in Uterine Doppler and Circulating Angiogenic Factors during the Third Trimester in Predicting Term Preeclampsia / $c L. Roubalova, V. Kroutilova, MF. Lopez-G Tinajero, J. Martinez-Egea, C. Pumarola, F. Figueras, M. Lubusky
- 520 9_
- $a INTRODUCTION: The objective of this study was to assess the relationship between longitudinal changes in the uterine Doppler velocimetry and the maternal profile of angiogenic factors in the third trimester and to assess their ability to predict term preeclampsia (PE). METHODS: A cohort of low-risk pregnant women was scheduled for a uterine Doppler evaluation and measurement of the circulating levels of angiogenic factors at ∼30 and ∼36 weeks. The performance of both parameters and their change over time in predicting term PE was evaluated. RESULTS: A total of 1,191 women were analyzed, of which 28 (2.4%) women developed term PE. At ∼30 weeks, a model including the sFlt-1/PlGF (fms-like tyrosine kinase-1/placental growth factor) ratio and the uterine Doppler explained 16.2% of the uncertainty of developing term PE, while at ∼36 weeks, the same variables explained 25.2% [p < 0.001]. The longitudinal changes of both predictors had an R2 of 26.8%, which was not different from that of the ∼36 weeks evaluation [p = 0.45]. The area under the curve (AUC) of the ∼36 weeks ratio was significantly higher than at ∼30 weeks (0.86 [0.77-0.94] vs. 0.81 [0.73-0.9]; p = 0.043). The AUC of the longitudinal change of the ratio (0.85 [0.77-0.94]) did not differ from that of at ∼36 weeks (p = 0.82). At ∼36 weeks, for a 10% of false positives, the ratio had a detection rate of 71.4%. CONCLUSION: A cross-sectional measurement of the sFlt-1/PlGF ratio outperforms uterine Doppler in predicting term PE. The combination of both markers does not improve such prediction, nor the evaluation of the longitudinal changes between weeks.
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a těhotenství $7 D011247
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a prediktivní hodnota testů $7 D011237
- 650 12
- $a třetí trimestr těhotenství $x krev $x fyziologie $7 D011263
- 650 _2
- $a ultrasonografie dopplerovská $x metody $x statistika a číselné údaje $7 D018608
- 650 12
- $a ultrasonografie prenatální $x metody $x statistika a číselné údaje $7 D016216
- 650 12
- $a preeklampsie $x krev $x diagnostické zobrazování $7 D011225
- 650 _2
- $a placentární oběh $x fyziologie $7 D021041
- 650 _2
- $a rychlost toku krve $x fyziologie $7 D001783
- 650 12
- $a reologie $x metody $x statistika a číselné údaje $7 D012212
- 650 _2
- $a plocha pod křivkou $7 D019540
- 650 12
- $a receptor 1 pro vaskulární endoteliální růstový faktor $x krev $7 D040281
- 650 12
- $a placentární růstový faktor $x krev $7 D000072483
- 650 _2
- $a reprodukovatelnost výsledků $7 D015203
- 655 _2
- $a srovnávací studie $7 D003160
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a multicentrická studie $7 D016448
- 655 _2
- $a randomizované kontrolované studie $7 D016449
- 700 1_
- $a Kroutilova, Vladimira $u Department of Obstetrics and Gynecology, Palacky University Olomouc, Olomouc, Czechia
- 700 1_
- $a Lopez-G Tinajero, Maria Fernanda $u BCNatal (Hospital Clinic and Hospital Sant Joan de Deu), Universitat de Barcelona, Barcelona, Spain
- 700 1_
- $a Martinez-Egea, Judit $u BCNatal (Hospital Clinic and Hospital Sant Joan de Deu), Universitat de Barcelona, Barcelona, Spain
- 700 1_
- $a Pumarola, Claudia $u BCNatal (Hospital Clinic and Hospital Sant Joan de Deu), Universitat de Barcelona, Barcelona, Spain
- 700 1_
- $a Figueras, Francesc $u BCNatal (Hospital Clinic and Hospital Sant Joan de Deu), Universitat de Barcelona, Barcelona, Spain
- 700 1_
- $a Lubusky, Marek $u Department of Obstetrics and Gynecology, Palacky University Olomouc, Olomouc, Czechia
- 773 0_
- $w MED00001797 $t Fetal diagnosis and therapy $x 1421-9964 $g Roč. 52, č. 3 (2025), s. 233-242
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/39496230 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20250708 $b ABA008
- 991 __
- $a 20250731092906 $b ABA008
- 999 __
- $a ok $b bmc $g 2366939 $s 1253560
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2025 $b 52 $c 3 $d 233-242 $e 20241104 $i 1421-9964 $m Fetal diagnosis and therapy $n Fetal Diagn Ther $x MED00001797
- LZP __
- $a Pubmed-20250708